Advancing outcomes of metastatic HER2-positive breast cancer

Lancet. 2023 May 27;401(10390):1746-1747. doi: 10.1016/S0140-6736(23)00805-X. Epub 2023 Apr 20.

Author

Saranya Chumsri¹

Affiliation

¹ Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL 32224, USA. Electronic address: chumsri.saranya@mayo.edu.

PMID: 37086743
DOI: 10.1016/S0140-6736(23)00805-X

No abstract available

Publication types

Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms* / drug therapy
Breast Neoplasms* / genetics
Female
Humans
Neoplasm Metastasis
Receptor, ErbB-2
Trastuzumab / therapeutic use

Substances

Trastuzumab
Receptor, ErbB-2